Impax Can't Shake Drug Quality-Control Securities Action
A California federal judge on Friday refused to toss a securities fraud class action against Impax Laboratories Inc. that alleges the pharmaceutical company hid serious quality-control deficiencies while exaggerating its progress...To view the full article, register now.
Already a subscriber? Click here to view full article